Side-by-side financials for BCAB and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BCAB | RVMD |
|---|---|---|
| Market cap | - | $31.73 B |
| US-listed rank | - | #448 |
| Revenue (latest FY) | $300.00K | $0.00 |
| Net income (latest FY) | -$59.61M | -$1.13B |
| Net margin | -19869.0% | - |
| SEC filings | 490 | 782 |
Full pages: BioAtla, Inc. and Revolution Medicines, Inc., or browse the full rankings.